GI Oncology Section Chief - Roswell Park Cancer Institute
The Section of Gastrointestinal Cancers and Department of Medicine is seeking a full-time medical oncologist at the Associate or full Professor level to lead our Medical Oncology GI Section. The GI Program is a vibrant multidisciplinary team of medical, surgical, and radiation oncologists, pathologists, radiologists, and basic scientists dedicated to understanding and treating GI malignancies. Responsibilities include leadership of the GI Medical Oncology Section, outpatient clinics, inpatient lymphoma service, clinical and translational research, participation and leadership in clinical trials, as well as teaching and supervision of fellows. Applicants are required to be BC/BE in oncology and be eligible for a NY State Medical License. The Program Chief will report directly to the Chair Department of Medicine. The search committee will consider clinical and translational research interests, publication record, and commitment to clinical care and teaching. Academic rank and compensation are dependent upon qualifications and years of experience. Faculty will also have a joint appointment at the University at Buffalo Jacobs School of Medicine. RPCI offers a generous fringe benefits package.
Since 1898, Roswell Park Cancer Institute has forged an exemplary reputation with the combined strength of its basic/translational research, multidisciplinary oncology teams, educational programs and compassionate staff. A seamless interface of scientific inquiry and clinical application and an aggressive clinical trials program, Roswell Park commits the infrastructure, intellectual capital and necessary resources to convert scientific discoveries into real-world products and applications. A charter member of the NCCN, Roswell Park is the only NCI-designated comprehensive cancer center in Upstate New York.
RPCI’s contributions to reducing the global cancer toll include initiating the world's first chemotherapy program; pioneering the prostate-specific antigen (PSA) test, photodynamic therapy and the combination chemotherapy of leucovorin and 5-FU (the gold standard for colon cancer treatment); developing the RPMI 1640 Culture Media (used in research labs around the world); and collaborating on landmark studies related to the Human Genome Project. Roswell Park initiated one of the nation's first centers dedicated to Early Phase Clinical Trials and drives innovative cancer research in genetics, cell stress and immunotherapy, leading to new personalized treatments.
Roswell Park Vital Stats FY 2016
- Employees: 3,263, including 299 faculty members and 627 nurses
- Hospital Admissions: 4,789
- Outpatient Visits: 215,424
- Patients Under Active Care: 33,979
- Patient Origin: 43 U.S. states, 6 foreign countries
- Number of Beds: 133
- Average Length of Stay: 8.2 days
- Grants/Contracts (per annum): $80.3M
- Funded Research Projects: 526
- License Agreements: 89
- U.S. Patents: 59
Highlights of Buffalo:
- Population = 258,959
- Known for Great American Architecture with over 80 sites on the National Register of Historic Places
- Professional sports - Buffalo Sabres (NHL) and Buffalo Bills (NFL)
- Two State Universities - State University of New York at Buffalo and Buffalo State College
- Toronto is just 1.5 hours
Interested candidates please contact:
Reference position ID 157297 when responding